| ProMIS Neurosciences to Report Third Quarter 2026 Financial Results and Business Update on November 12, 2026 |
Globe Newswire |
11/03 |
07:00 |
| LGI Homes, Inc. Reports Third Quarter 2026 Results |
Globe Newswire |
11/03 |
07:00 |
| Fiserv Reports Third Quarter 2026 Results |
Globe Newswire |
11/03 |
07:00 |
| OTC Markets Group Announces Quarterly Index Performance and Rebalancing |
Globe Newswire |
11/03 |
07:00 |
| Teva’s Pivot to Growth Strategy Delivers 33% Growth Across Key Innovative Brands; Raises 2026 Outlook for AUSTEDO®, AJOVY® and UZEDY®; Delivers Substantial Gross Margin Expansion |
Globe Newswire |
11/03 |
07:00 |
| Shopify Sustains Rapid Growth with Revenue Up 32% and Free Cash Flow Margin of 22% |
Globe Newswire |
11/03 |
07:00 |
| InflaRx Highlights Izicopan Development Path and Commercial Opportunity in ANCA-Associated Vasculitis at Capital Markets Day |
Globe Newswire |
11/03 |
07:00 |
| Seres Therapeutics Announces Publication of SER-155 Phase 1b Results in Nature Medicine Showing Reduced Bloodstream Infections in Allogeneic Hematopoietic Cell Transplantation Recipients |
Globe Newswire |
11/03 |
07:00 |
| Anavex Life Sciences Names Terrie Kellmeyer, Ph.D., as President and Chief Executive Officer and Member of the Board of Directors |
Globe Newswire |
11/03 |
07:00 |
| Strata Critical Medical Announces Third Quarter 2026 Results |
Globe Newswire |
11/03 |
07:00 |
| Relmada Therapeutics to Report Third Quarter 2026 Financial Results on Thursday, November 12, 2026 |
Globe Newswire |
11/03 |
07:00 |
| Hemab Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 10, 2026 |
Globe Newswire |
11/03 |
07:00 |
| Aurora Mobile's EngageLab Partners with SKYWORTH Solar to Support Global Channel Operations and Project Delivery with AppPush |
Globe Newswire |
11/03 |
07:00 |
| First Watch Restaurant Group, Inc. Reports Q3 2026 Financial Results |
Globe Newswire |
11/03 |
07:00 |
| Talen Energy Reports Third Quarter 2026 Results, Reaffirms 2026 Guidance, and Introduces 2027 Guidance |
Globe Newswire |
11/03 |
07:00 |
| Luckin Coffee Announces Third Quarter 2026 Financial Results |
Globe Newswire |
11/03 |
07:00 |
| Beam Therapeutics Reports Third Quarter 2026 Financial Results and Highlights Clinical Progress Across Base Editing Portfolio |
Globe Newswire |
11/03 |
07:00 |
| Evestia Clinical Acquires Emtex Life Science to Further Enhance its Global Full-Service Clinical Research Capabilities |
Globe Newswire |
11/03 |
07:00 |
| Sportradar Reports Third Quarter 2026 Financial Results |
Globe Newswire |
11/03 |
07:00 |
| Rhythm Pharmaceuticals Reports Third Quarter 2026 Financial Results and Business Update |
Globe Newswire |
11/03 |
07:00 |
| Arvinas Reports Third Quarter 2026 Financial Results and Provides Corporate Update |
Globe Newswire |
11/03 |
07:00 |
| MitoRx Therapeutics Appoints Neil Anderson as Chief Business Officer |
Globe Newswire |
11/03 |
07:00 |
| Pasithea Therapeutics Announces FDA Clearance of IND for PAS-004 in Neurofibromatosis Type 1 (NF1)-Associated Cutaneous Neurofibromas (cNF) |
Globe Newswire |
11/03 |
07:00 |
| Axsome Therapeutics to Participate in Upcoming Investor Conferences |
Globe Newswire |
11/03 |
07:00 |
| Madrigal Pharmaceuticals Reports Third-Quarter 2026 Financial Results and Provides Corporate Updates |
Globe Newswire |
11/03 |
07:00 |